Xiong J, Li J, Zhao G
Department of General Surgery, Xiehe Hospital, Tongji Medical University, Wuhan 430022.
J Tongji Med Univ. 2000;20(4):345-6. doi: 10.1007/BF02888201.
The failure causes of percutaneous implantable port (PIP) for tumor chemotherapy were analyzed and the appropriate preventing measures were put forward. During Feb. 1995 to Feb. 1999, 10 patients with tumor undergoing failure insertion of PIP were retrospectively studied. We placed the PIP in the hepatic artery in 3 patients with liver carcinoma after operation, in the internal iliac artery in 5 patients with colonic or rectal carcinoma after operation and in the left gastric artery in 2 patients with stomach carcinoma after operation. The results showed that in the 10 patients, chemotherapeutic agent effusion around the PIP and local tissue necrosis in 5 cases, infection and abscess formation around the PIP in 3 cases, PIP body rupture in one case and the catheter sliding into the internal iliac artery occurred. It was concluded that taking measures during PIP insertion could prevent the occurrence of complications and is beneficial to the implementation of scheduled chemotherapeutic protocol for the patients.
分析了肿瘤化疗用经皮植入式端口（PIP）的失败原因，并提出了相应的预防措施。回顾性研究了1995年2月至1999年2月期间10例PIP植入失败的肿瘤患者。我们对3例肝癌术后患者将PIP置于肝动脉，5例结直肠癌或直肠癌术后患者置于髂内动脉，2例胃癌术后患者置于胃左动脉。结果显示，10例患者中，5例出现PIP周围化疗药物渗漏及局部组织坏死，3例出现PIP周围感染及脓肿形成，1例PIP主体破裂，1例导管滑入髂内动脉。结论是在PIP植入过程中采取措施可预防并发症的发生，有利于患者按计划实施化疗方案。
